Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice

Inflammation

Volumn 33, Issue 5, 2010, Pages 306-314

  Chen, Zhibao ^a,b   Zhang, Xuemei ^c   Chu, Xiao ^a   Zhang, Xiaozhe ^a   Song, Keji ^b   Jiang, Youshuai ^b   Yu, Lu ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

^c YANBIAN UNIVERSITY   (China)

Author keywords

acute lung injury; cytokine; LPS; valnemulin

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALNEMULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; HISTOPATHOLOGY; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN DETERMINATION;

ACUTE LUNG INJURY; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DITERPENES; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; PEROXIDASE; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 77956063983     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-010-9186-3     Document Type: Article

References (33)

1. S Fujishima N Aikawa 1995 Neutrophil-mediated tissue injury and its modulation Intensive Care Medicine 21 277 285 10.1007/BF01701489 1:STN:280:DyaK2MzhtVKgsg%3D%3D 7790621
2. LB Ware MA Matthay 2000 The acute respiratory distress syndrome New England Journal of Medicine 342 1334 1349 10.1056/NEJM200005043421806 1:STN:280:DC%2BD3c3jvFGhsw%3D%3D 10793167
3. K Bosma V Fanelli VM Ranieri 2005 Acute respiratory distress syndrome: update on the latest developments in basic and clinical research Current Opinion in Anaesthesiology 18 137 145 10.1097/01.aco.0000162831.41097.6b 16534329
4. WL Lee GP Downey 2001 Neutrophil activation and acute lung injury Current Opinion in Critical Care 7 1 7 10.1097/00075198-200102000-00001 1:STN:280:DC%2BD3MzltVersA%3D%3D 11373504
5. M Bhatia S Moochhala 2004 Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome Journal of Pathology 202 145 156 10.1002/path.1491 1:CAS:528:DC%2BD2cXhvVKjtr4%3D 14743496
6. NC Riedemann RF Guo PA Ward 2003 The enigma of sepsis Journal of Clinical Investigation 112 460 467 1:CAS:528:DC%2BD3sXms1WntLY%3D 12925683
7. RM Strieter SL Kunkel MP Keane TJ Standiford 1999 Chemokines in lung injury: Thomas A Neff Lecture Chest 116 103S 110S 10.1378/chest.116.suppl-1.103S 1:CAS:528:DyaK1MXltVKrtL0%3D 10424625
8. Y Kitamura S Hashimoto N Mizuta A Kobayashi K Kooguchi I Fujiwara H Nakajima 2001 Fas/Fasl-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice American Journal of Respiratory and Critical Care Medicine 163 762 769 1:STN:280:DC%2BD3M3itFGlsQ%3D%3D 11254536
9. Y Wu M Singer F Thouron M Alaoui-El-Azher L Touqui 2002 Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury American Journal of Physiology. Lung Cellular and Molecular Physiology 282 L743 L750 1:CAS:528:DC%2BD38XivVelt7c%3D 11880300
10. Koller, K., and F. Schwarz. 2001. Formulation of valnemulin [P]. US:6284792.
11. Windsor, H.M., P.H. Ripley, P.C.T. Hannan 1996. An in vitro investigation of the sensitivity of German field isolates of M. hyopneumoniae and M. hyosynoviae to SDZ PMD 296, a new pleuromulin derivate. In: Proceedings of the 14th IPVS Congress, 226. Bologna, Italy.
12. PC Hannan HM Windsor PH Ripley 1997 in vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae Research in Veterinary Science 63 157 160 10.1016/S0034-5288(97)90010-2 1:CAS:528:DyaK1cXktlaisA%3D%3D 9429250
13. KS Long LH Hansen L Jakobsen B Vester 2006 Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center Antimicrobial Agents and Chemotherapy 50 1458 1462 10.1128/AAC.50.4.1458-1462.2006 1:CAS:528:DC%2BD28XjvFOrsL0%3D 16569865
14. C Heilmann L Jensen JS Jensen K Lundstrom D Windsor H Windsor D Webster 2001 Treatment of resistant Mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic Journal of Infection 43 234 238 10.1053/jinf.2001.0910 1:STN:280:DC%2BD387jt1Kitg%3D%3D 11869060
15. X Zhang H Li H Feng H Xiong L Zhang Y Song L Yu X Deng 2009 Valnemulin downregulates nitric oxide, prostaglandin E2, and cytokine production via inhibition of NF-kappaB and MAPK activity International Immunopharmacology 9 810 816 10.1016/j.intimp.2009.02.018 1:CAS:528:DC%2BD1MXms1Oku7o%3D 19293003
16. DK Ysebaert GKE De SR Vercauteren M Ghielli GA Verpooten EJ Eyskens BME De 2000 Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury Nephrology, Dialysis, Transplantation 15 1562 1574 10.1093/ndt/15.10.1562 1:STN:280:DC%2BD3M%2FktVWrsw%3D%3D 11007823
17. LC Mongan T Jones G Patrick 2000 Cytokine and free radical responses of alveolar macrophages in vitro to asbestos fibres Cytokine 12 1243 1247 10.1006/cyto.2000.0700 1:CAS:528:DC%2BD3cXltlOqsbc%3D 10930305
18. R Shimazu S Akashi H Ogata Y Nagai K Fukudome K Miyake M Kimoto 1999 MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 Journal of Experimental Medicine 189 1777 1782 10.1084/jem.189.11. 1777 1:CAS:528:DyaK1MXjvVSnu78%3D 10359581
19. RJ Szarka N Wang L Gordon PN Nation RH Smith 1997 A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation Journal of Immunological Methods 202 49 57 10.1016/S0022-1759(96)00236-0 1:CAS:528:DyaK2sXhtlyht7Y%3D 9075771
20. P von Bismarck K Klemm WCF García S Winoto-Morbach S Schütze MF Krause 2009 Selective NF-kappaB inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model Pulmonary Pharmacology and Therapeutics 22 297 304 10.1016/j.pupt.2009.02.002
21. R Lucas AD Verin SM Black JD Catravas 2009 Regulators of endothelial and epithelial barrier integrity and function in acute lung injury Biochemical Pharmacology 77 1763 1772 10.1016/j.bcp.2009.01.014 1:CAS:528: DC%2BD1MXlsVKltLk%3D 19428331
22. NC Staub Sr KE Longworth V Serikov EH Jerome T Elsasser 2001 Detergent inhibits 70-90% of responses to intravenous endotoxin in awake sheep Journal of Applied Physiology 90 1788 1797 10.1063/1.1383581 1:CAS:528:DC%2BD3MXjsFert74%3D 11299269
23. Y Sone VB Serikov NC Staub Sr 1999 Intravascular macrophage depletion attenuates endotoxin lung injury in anesthetized sheep Journal of Applied Physiology 87 1354 1359 1:STN:280:DyaK1MvkslOhtQ%3D%3D 10517763
24. K Mecklenburgh J Murray T Brazil C Ward AG Rossi ER Chilvers 1999 Role of neutrophil apoptosis in the resolution of pulmonary inflammation Monaldi Archives for Chest Disease 54 345 349 1:STN:280:DC%2BD3c%2FhtlyjsA%3D%3D 10546479
25. JM Cavaillon M Adib-Conquy 2005 Monocytes/macrophages and sepsis Critical Care Medicine 33 S506 S509 10.1097/01.CCM.0000185502.21012.37 16340435
26. SJ Klebanoff 2005 Myeloperoxidase: Friend and foe Journal of Leukocyte Biology 77 598 625 10.1189/jlb.1204697 1:CAS:528:DC%2BD2MXktFentLw%3D 15689384
27. CC Winterbourn MC Vissers AJ Kettle 2000 Myeloperoxidase Current Opinion in Hematology 7 53 58 10.1097/00062752-200001000-00010 1:STN:280: DC%2BD3c%2FnsVajtg%3D%3D 10608505
28. E Roth N Manhart B Wessner 2004 Assessing the antioxidative status in critically ill patients Current Opinion in Clinical Nutrition and Metabolic Care 7 161 168 10.1097/00075197-200403000-00010 1:CAS:528:DC%2BD2cXjtFGjtLg%3D 15075707
29. J Ueda ME Starr H Takahashi J Du LY Chang JD Crapo BM Evers H Saito 2008 Decreased pulmonary extracellular superoxide dismutase during systemic inflammation Free Radical Biology and Medicine 45 897 904 10.1016/j. freeradbiomed.2008.06.016 1:CAS:528:DC%2BD1cXhtVylsbfI 18640266
30. VL Kinnula JD Crapo 2003 Superoxide dismutases in the lung and human lung diseases American Journal of Respiratory and Critical Care Medicine 167 1600 1619 10.1164/rccm.200212-1479SO 12796054
31. J Bhattacharyya S Biswas AG Datta 2004 Mode of action of endotoxin: role of free radicals and antioxidants Current Medicinal Chemistry 11 359 368 10.2174/0929867043456098 1:CAS:528:DC%2BD2cXhs1SqsrY%3D 14965237
32. CL Fattman LM Schaefer TD Oury 2003 Extracellular superoxide dismutase in biology and medicine Free Radical Biology and Medicine 35 236 256 10.1016/S0891-5849(03)00275-2 1:CAS:528:DC%2BD3sXls1Omsbk%3D 12885586
33. J Macdonald HF Galley NR Webster 2003 Oxidative stress and gene expression in sepsis British Journal of Anaesthesia 90 221 232 10.1093/bja/aeg034 1:CAS:528:DC%2BD3sXit1GqsLw%3D 12538380